ID: ALA4100580

Max Phase: Preclinical

Molecular Formula: C15H9Cl2FN2

Molecular Weight: 307.15

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Fc1ccc(-c2cnc(Cl)n2-c2ccc(Cl)cc2)cc1

Standard InChI:  InChI=1S/C15H9Cl2FN2/c16-11-3-7-13(8-4-11)20-14(9-19-15(20)17)10-1-5-12(18)6-2-10/h1-9H

Standard InChI Key:  OGVDBCQSIXFAGX-UHFFFAOYSA-N

Associated Targets(non-human)

Cyclooxygenase 970 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 307.15Molecular Weight (Monoisotopic): 306.0127AlogP: 4.99#Rotatable Bonds: 2
Polar Surface Area: 17.82Molecular Species: NEUTRALHBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.27CX LogP: 4.96CX LogD: 4.96
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.65Np Likeness Score: -1.64

References

1. Cornec AS, Monti L, Kovalevich J, Makani V, James MJ, Vijayendran KG, Oukoloff K, Yao Y, Lee VM, Trojanowski JQ, Smith AB, Brunden KR, Ballatore C..  (2017)  Multitargeted Imidazoles: Potential Therapeutic Leads for Alzheimer's and Other Neurodegenerative Diseases.,  60  (12): [PMID:28530811] [10.1021/acs.jmedchem.7b00475]

Source